She kept the log on her phone for two years. Sixteen entries on the worst days. Time, how long, whether she had to change her shirt.
She showed it to her gynaecologist, who was kind about it. She showed it to her GP, who prescribed something for sleep. Nobody showed it to the nurse who took her blood pressure that spring and ticked a box marked cardiovascular risk. Nobody thought the two pages belonged in the same file.
She was 51.
When women come to the platform and list what is happening in their bodies, hot flashes and night sweats land under quality of life almost every time. Sleep is disturbed. Work is harder. Clothes get chosen strategically. Heart appears somewhere else on the form, if it appears at all, usually as family history.
I understand why. That is how this symptom was explained to us for forty years, and it is how most appointments are still built. But the research moved and the appointment did not, and the distance between those two things is measured in years of a woman’s life.
I built EmpressHealth.ai because I kept watching women hand over accurate data that nobody read as a whole. This week I want to change how you read your own.
A hot flash is a vascular event.
It happens in your blood vessels. It involves your nervous system, your vessel walls and your blood pressure, live, in the moment it is happening. Your blood vessels are the exact organ system a cardiologist spends a career worrying about.
We have been recording the same event in two separate folders and treating it as two separate things.
What SWAN found across 22 years and 3,083 women
The Study of Women’s Health Across the Nation followed 3,083 women who were between 42 and 52 when they enrolled, for more than two decades. Researchers recorded how often each woman had hot flashes and night sweats. They also recorded cardiovascular events: heart attack, stroke, heart failure, revascularisation. Over the follow up, 231 women had one.
Women with frequent vasomotor symptoms, defined as six or more days in a two week window, and women whose symptoms stayed frequent year after year, had a 50 to 77 percent higher risk of a later cardiovascular event than women with no symptoms.
The part that matters most is what came after that number. The association held once researchers adjusted for the standard risk factors: blood pressure, cholesterol, body mass index, smoking, physical activity, insulin resistance, medication use. It was not explained away by the women’s measured estradiol levels either. The authors’ conclusion was that vasomotor symptoms may be a cardiovascular risk marker specific to women that medicine has not been using.
Not a symptom to endure. A signal to read.
Why the vessels, and not just the thermostat
Earlier work in the same cohort, SWAN Heart, looked inside the arteries rather than at events decades later. Women with hot flashes showed poorer endothelial function, greater aortic calcification, and greater carotid intima media thickness than women without them.
Two of those terms are worth translating properly.
The endothelium is the single cell lining on the inside of every blood vessel you own. It is the tissue that tells a vessel when to relax and open. Its function is measured with flow mediated dilation: a cuff briefly stops blood flow in the arm, the cuff releases, and ultrasound watches how well the artery opens back up. It is one of the earliest signals of arterial trouble available, years ahead of anything visible on a standard test.
Carotid intima media thickness is the thickness of the inner layers of the neck artery wall, measured on ultrasound. It thickens before plaque becomes visible.
So the sequence is not: hot flashes now, heart disease decades later, nothing connecting the two. It is one estrogen decline changing how your vessels behave, showing up first as heat you can feel and second as measurements you cannot.
The window and the symptom overlap, and neither one waits
In 2020 the American Heart Association published a scientific statement making the case that the menopause transition itself, separate from simply getting older, is a stretch of accelerating cardiovascular risk, and that midlife is the window for prevention rather than the moment to start watching. That statement also addresses the timing question around hormone therapy, where risk profiles look more favourable when therapy begins before age 60 or within 10 years of menopause.
I am not telling you what to take. That is a conversation with a clinician who knows your history, your family and your risk. I am telling you the window and the symptom sit on top of each other, and that both of them are moving.
The woman with two years of logs did one thing differently at her next appointment. She put her phone on the desk before the cuff went on her arm and said: I have had frequent flashes for two years, and I would like my cardiovascular risk looked at with that in the picture.
She did not get a diagnosis that day. She got a lipid panel, a week of blood pressure readings taken at home, and a follow up booked before she left. That is what being taken seriously actually looks like. It is unglamorous and it is early, and early is the entire point.
Frequent, persistent hot flashes and night sweats are not only a comfort problem. For many women they are among the earliest visible signals of how the vascular system is handling this transition.
If you take one thing from this letter, take the sentence. At your next appointment, say: I have frequent vasomotor symptoms, and I would like my cardiovascular risk assessed in that context. Ask for blood pressure, a lipid panel and blood glucose at a minimum.
Then keep the record. Frequency and how long it has been going on are the two details this research cares about, which makes them the two details worth writing down.